Key result
A large daily dose of an ACE inhibitor lowered the hospitalization rate and showed a trend toward lower mortality compared to a low daily dose in patients with heart failure.
Why the study?
Does a large daily dose of an ACE inhibitor reduce mortality and hospitalization in patients with heart failure compared to a low daily dose?
RCT
randomized
Does a large daily dose of an ACE inhibitor reduce mortality and hospitalization in patients with heart failure compared to a low daily dose?
Answers are grounded in this paper and cite their sources.
Maximal tolerated doses of ACE inhibitors should be used in heart failure patients to optimize clinical benefits, including reduced hospitalizations.
In a large, randomized study, patients with heart failure who received a large daily dose of an angiotensin-converting inhibitor had a trend toward a lower mortality rate than did patients who received a low daily dose. Moreover, the hospitalization rate was lower in the high-dose group, and the side-effect profile was the same in both groups. Physicians should try to give maximal doses to achieve optimum benefit in this patient population.
No takes yet. Share an insight, caveat, or question.
Robert E. Hobbs (1998) conducted an RCT in heart failure. ACE inhibitor vs. low daily dose was evaluated on mortality rate. A large daily dose of an ACE inhibitor lowered the hospitalization rate and showed a trend toward lower mortality compared to a low daily dose in patients with heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: